FRANCESCO DEMAYO to In Situ Nick-End Labeling
This is a "connection" page, showing publications FRANCESCO DEMAYO has written about In Situ Nick-End Labeling.
Connection Strength
0.051
-
PDX-1 is a therapeutic target for pancreatic cancer, insulinoma and islet neoplasia using a novel RNA interference platform. PLoS One. 2012; 7(8):e40452.
Score: 0.026
-
Dysregulation of uterine signaling pathways in progesterone receptor-Cre knockout of dicer. Mol Endocrinol. 2012 Sep; 26(9):1552-66.
Score: 0.026